US 10487088
Tricyclic compound serving as immunomodulator
granted A61KA61K31/407A61K31/5377
Quick answer
US patent 10487088 (Tricyclic compound serving as immunomodulator) held by Medshine Discovery Inc. expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/407, A61K31/5377, A61P, A61P31/00